LifeStance Health reported a standout third quarter with 17% organic visit growth and record-high adjusted EBITDA margins, reinforcing its robust operational model and strategic positioning in the mental health sector.
- Revenue reached $364 million, reflecting a 16% year-over-year increase driven by strong visit volumes.
- Achieved adjusted EBITDA of $40 million, marking an 11% margin, the highest since going public in 2021.
- Added a record 288 organic clinicians, bringing the total to nearly 8,000, enhancing patient access and service quality.
- Partnership with Calm expands referral capabilities, enhancing patient pathways to care.
- Full-year guidance for adjusted EBITDA raised, indicating strong confidence in ongoing growth momentum.
Community Discussion